Home
Live Updates
Lineage Cell Therapeutics : Prospectus disclosing information, facts, events : comparemela.com
Lineage Cell Therapeutics : Prospectus disclosing information, facts, events
Filed Pursuant to Rule 424
Registration No. 333-277758
PROSPECTUS SUPPLEMENT
Up to $39,966,424...
Related Keywords
Israel ,
State Of California ,
California ,
United States ,
Tel Aviv ,
American ,
,
Roche Ltd ,
Lineage Cell Therapeutics Inc ,
Securities Exchange ,
American Company ,
Tel Aviv Stock Exchange ,
Eterna Therapeutics Inc ,
Exchange Commission ,
Implications Of Beinga Smaller Reporting Company ,
Roche Group ,
California Institute For Regenerative Medicine ,
B Riley Securities Inc ,
Genentech ,
Genentech Inc ,
Filed Pursuant ,
Securities Act ,
Can Find More ,
Certain Information ,
Lineage Cell Therapeutics ,
License Agreement ,
California Institute ,
Investigational New Drug ,
Oligodendrocyte Progenitor Cells ,
Spinal Cord Injury ,
Novel Device ,
Smaller Reporting Company ,
Securities Exchange Act ,
Sarbanes Oxley Act ,
Incentive Plan ,
Company Guide ,
Annual Report ,
Financial Condition ,
Quarterly Report ,
Exchange Act ,
comparemela.com © 2020. All Rights Reserved.